Cancer Immunotherapy: Metabolism & the Tumor Microenvironment

The Metabolic Battlefield: How Cancer Immunotherapy is Rewriting the Rules of Immune Cell Fueling A groundbreaking shift is underway in cancer treatment, moving beyond simply targeting tumor cells to understanding and manipulating the intricate metabolic processes that govern both cancer and the immune system. Recent research reveals a complex “crosstalk” between tumor metabolism and immune … Read more

Sonelokimab: PsA Relief with IL-17 Nanobody – Phase 2 Trial

New Nanobody Therapy Shows Promise for Psoriatic Arthritis Patients Groundbreaking results from a phase 2 clinical trial offer renewed hope for individuals battling psoriatic arthritis. The ARGO trial demonstrated that a novel nanobody, designed to target both IL-17A and IL-17F, significantly improved disease response rates compared to a placebo in patients with active forms of … Read more